Cargando…

Adjuvant therapy for melanoma: How should we respond to high-dose interferon?

Detalles Bibliográficos
Autores principales:	de Takats, P. G., Williams, M. V., Hawkins, R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150169/ https://www.ncbi.nlm.nih.gov/pubmed/9579835

Ejemplares similares

Cost‐effectiveness of ipilimumab versus high‐dose interferon as an adjuvant therapy in resected high‐risk melanoma
por: Salans, Mia, et al.
Publicado: (2021)

What is “moral distress” in nursing? How, can and should we respond to it?
por: Morley, Georgina
Publicado: (2018)

A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma
por: Suarez-Kelly, Lorena P., et al.
Publicado: (2019)

Adjuvant interferon in the treatment of melanoma
por: Middleton, M R
Publicado: (1999)

Adjuvant interferon in the treatment of melanoma
por: Kirkwood, J M
Publicado: (2000)

Adjuvant therapy of melanoma with interferon: lessons of the past decade
por: Ascierto, Paolo A, et al.
Publicado: (2008)

Why should we need the gut microbiota to respond to cancer therapies?
por: Viaud, Sophie, et al.
Publicado: (2014)

Adjuvant interferon in melanoma – a resurrection?
por: Middleton, M R, et al.
Publicado: (2001)

Adjuvant interferon in the treatment of melanoma – reply
por: Middleton, M R
Publicado: (2000)

The ‘novel’ influenza A(H1N1) enigma: is it a pandemic, how should we respond, what should we call it?
por: Hampson, Alan W.
Publicado: (2009)

How we should respond to the Coronavirus SARS-CoV-2 outbreak: A German perspective
por: Jung, F., et al.
Publicado: (2020)

Respondent driven sampling—where we are and where should we be going?
por: White, Richard G, et al.
Publicado: (2012)

Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice
por: Ravaud, A, et al.
Publicado: (1999)

The cholera challenge: How should the world respond?
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2022)

The Ukraine question: how should the south respond?
por: Kaur, Ravinder
Publicado: (2022)

How should we conduct pandemic vaccination?
por: Williams, Jane, et al.
Publicado: (2021)

How Should Prey Animals Respond to Uncertain Threats?
por: Zylberberg, Joel, et al.
Publicado: (2011)

USA stockpiling of remdesivir: How should the world respond?
por: Dawoud, Dalia, et al.
Publicado: (2020)

Adjuvant interferon alpha 2b in high risk melanoma – the Scottish study
por: Cameron, D A, et al.
Publicado: (2001)

Adjuvant therapy for high-risk melanoma
por: Eggermont, Alexander M.M.
Publicado: (2013)

How do we and how should we deal with uncertainty in endodontics?
por: Pigg, Maria, et al.
Publicado: (2022)

How Should we Handle Safety?
por: Albert, M, et al.
Publicado: (2001)

How Should We Manage Myelofibrosis?
por: Pegrum, G. D., et al.
Publicado: (1981)

How Should the Health Community Respond to Violent Political Conflict?
por: Zwi, Anthony B
Publicado: (2004)

How Should Journal Editors Respond to Cases of Suspected Misconduct?
por: Wager, Elizabeth
Publicado: (2014)

Misinformation During COVID: How Should Nurse Practitioners Respond?
por: Russell, Naila
Publicado: (2021)

Uncertainty and COVID-19: how are we to respond?
por: Koffman, Jonathan, et al.
Publicado: (2020)

Adjuvant Therapy: Melanoma
por: Davar, Diwakar, et al.
Publicado: (2011)

Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity!
por: Abdel-Razeq, Hikmat
Publicado: (2021)

Noninvasive ventilation for acute lung injury: how often should we try, how often should we fail?
por: Garpestad, Erik, et al.
Publicado: (2006)

Oestrogen receptor beta: how should we measure this?
por: Speirs, V, et al.
Publicado: (2002)

Should we treat pyrexia? And how do we do it?
por: Doyle, James F., et al.
Publicado: (2016)

How we treat locoregional melanoma
por: Troiani, T., et al.
Publicado: (2021)

How Should We Organize the Higgs Safari?
por: Janot, P
Publicado: (1999)

Future collapse: how optimistic should we be?
por: Ehrlich, Paul R., et al.
Publicado: (2013)

How should we address the pipeline problem?
por: Braun, Hillary J.
Publicado: (2016)

Elastomeric pumps: How cautious should we be?
por: Ray, Swarup, et al.
Publicado: (2018)

How Should We Classify Kawasaki Disease?
por: Marrani, Edoardo, et al.
Publicado: (2018)

FMT in IBS: how cautious should we be?
por: El-Salhy, Magdy
Publicado: (2021)

Should we reconsider how to assess eutrophication?
por: Polimene, L, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_utp2elu89c796vbslm376jedc5